USPTO serial 85583401
BIAL
Reviewed by CopyMark Law Group
Reg. 4490162Status 710
- Filing date
- Status date
- Registration date
- Mar 4, 2014
- Examiner
- GAYNOR, BARBARA ANNE
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.
Need help with BIAL?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Sao Mamede Coronado, PT
Sao Mamede Coronado, PT
Sao Mamede Coronado, PT
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
James L. Bikoff
JAMES L BIKOFF Smith, Gambrell & Russell1055 Thomas Jefferson Street, NWSuite 400Washington, DC 20007Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceutical preparations for the treatment of cardiovascular diseases, urological disorders, gastrointestinal disorders, allergies, diabetes, hypertension, erectile dysfunction, sexual dysfunction, stroke, cancer, migraines, obesity and respiratory diseases, fungal disorders; pharmaceutical preparations, namely, anti-inflammatory analgesics; pharmaceutical preparations, namely, cholesterol reducers, smoking cessation preparations, tissue and skin repair preparations; pharmaceutical preparations, namely, decongestants and anti-histamines; pharmaceutical preparations for the treatment of pains, cough, fever, angina, otorhinolaryngological diseases, gastric and liver illnesses, heart illnesses, arterial and venous illnesses, rheumatic illnesses; anaesthetics; analgesics; frostbite salve for pharmaceutical purposes; hemorrhoid treatment preparations; pharmaceutical preparations for the treatment of headaches; medicines for alleviating constipation; contraceptive preparations; radiological contrast substances for medical purposes; diagnostic preparations for medical purposes; pharmaceuticals for the treatment of pain, fever, angina, otorhinolaryngological diseases, gastric and liver illnesses, heart illnesses, arterial and venous illnesses, rheumatic illnesses; pharmaceutical preparations for the treatment of diabetes, cancer; pharmaceutical preparations for the prevention and treatment of cancer, carcinomas and sarcomas; pharmaceutical preparations for the prevention and treatment of tumours of any description; pharmaceutical preparations, namely, platelet stimulating factors; pharmaceutical preparations for the treatment of the central nervous system, namely, encephalitis, epilepsy, bipolar disorder, neuropathic pain, migraine, generalized anxiety disorder, social phobia, diabetic neuropathies, panic disorder, postoperative pain, back pain, fibromyalgia, and postherpetic neuralgia, post-traumatic stress disorder, Parkinson's disease, Alzheimers; pharmaceutical preparations for the treatment of psychiatric diseases, namely, schizophrenia, anxiety disorders, mood disorders, cognitive disorders, depression, mania; pharmaceutical preparations and substances for the prevention and treatment of diseases and disorders of the respiratory system; pharmaceutical preparations for treatment of gout, namely, broncho-dilators and anti-asthmatic preparations; pharmaceutical preparations and substances for the prevention and treatment of diseases and disorders of the peripheral nervous system, cardiovascular system, gastro-intestinal system; prescription pharmaceutical preparations and substances for use in pain control, anaesthesia, oncology; prescription pharmaceutical preparations and substances for the treatment and prevention of diabetes; pharmaceutical preparations and substances, namely, antibiotics, antivirals, antidiabetic preparations, nondepolarizing skeletal neuromuscular blocking agents, hemostatic agents, expectorants, anti-leukemia agents, anti-arrhythmics, dermatologicals and vasopressors; pharmaceutical preparations and substances for the treatment of cancer, HIV, obesity, and respiratory and urologic disorders and diseases; pharmaceutical preparations and substances for the treatment of acute ischemic stroke and traumatic brain injury (TBI); cerebral vasodilators; pharmaceutical preparations for the treatment of smooth muscle disorders, headaches, wrinkles, hyperhydrosis, sports injuries, namely, injured or torn skin, muscle, ligaments or bone, tremors, namely, spasmodic smooth, striated or cardiac muscles, and pain, namely, smooth muscle pain, striated muscle pain, cardiac muscle pain, neuropathic pain, inflammatory pain, visceral pain, chronic pain, acute pain, traumatic injury pain, referred pain, growing pain, hunger pain, intractable pain, labour pain, organic pain, phantom limb pain, postprandial pain, psychogenic pain, back pain, post-stroke pain, cancer pain, nociceptive pain, headache pain, prostatic pain, and bladder pain; pharmaceutical preparations for the treatment of muscle dystonias, nerve disorders, and spasmodic striated, smooth or cardiac muscles; pharmaceutical preparations for the treatment of cerebral palsy; pharmaceutical preparations, namely, muscle relaxants and anti-emetics, xanthine oxidase inhibitors; pharmaceutical preparations, namely, scabicides, anti-malarials | SECTION 8 - CANCELLED | — |
| 042 | Pharmaceutical, medical and biological research and development in the field of human therapeutics; conducting of pre-clinical and clinical test research in the pharmaceutical and medical fields; scientific research and development in the field of human medicine | SECTION 8 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by BIAL-Portela & Ca., S.A.
- Other trademarks owned by BIAL-Portela & Ca., S.A.
- Other trademarks owned by BIAL-Portela & Ca., S.A.
- Other trademarks in Class 005
- Other trademarks in Class 042
- Similar marks named BIAL
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Oct 9, 2020 | C8.. | CANCELLED SEC. 8 (6-YR) | — |
| Mar 4, 2019 | REM1 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED | — |
| Jan 15, 2015 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Mar 4, 2014 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jan 28, 2014 | PAPER RECEIVED | — | |
| Jan 28, 2014 | TMBN | TTAB RELEASE CASE TO TRADEMARKS | — |
| Jan 28, 2014 | OP.T | OPPOSITION TERMINATED NO. 999999 | — |
| Jan 28, 2014 | OP.D | OPPOSITION DISMISSED NO. 999999 | — |
| Jul 16, 2013 | OP.I | OPPOSITION INSTITUTED NO. 999999 | — |
| Apr 16, 2013 | ETOF | EXTENSION OF TIME TO OPPOSE RECEIVED | — |
| Mar 19, 2013 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Mar 19, 2013 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Feb 27, 2013 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Feb 11, 2013 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Feb 11, 2013 | ALIE | ASSIGNED TO LIE | — |
| Jan 31, 2013 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jan 11, 2013 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jan 11, 2013 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jan 11, 2013 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jul 11, 2012 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jul 11, 2012 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jul 11, 2012 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jul 10, 2012 | DOCK | ASSIGNED TO EXAMINER | — |
| Apr 4, 2012 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Apr 2, 2012 | NWAP | NEW APPLICATION ENTERED | — |